Harding Loevner@hardingloevner·15 KasBiosimilars—cheaper copies of complex biologic drugs—could be the pharmaceutical industry’s next big growth opportunity. Watch our latest #FundamentalThinking video to find out why. bit.ly/2Fk7yvvÇevir English0010